The vast majority of benign tumours of the breast do not proceed to malignancy. Occasional giant fibroadenomas in older women may undergo malignant transformation but when this occurs it is much more often sarcomatous than carcinomatous. Papillomas, which are often solitary, very rarely undergo malignant change despite the pleomorphism of cells and nuclei that may be seen. Sequestration by fibrosis at the edge may simulate infiltration and even mimic perineural invasion but these appearances do not affect the excellent prognosis. True papillary carcinoma is very unusual and arises independently of preexisting benign papilloma.
There is continuing debate about the relationship between cystic mastopathy and carcinoma. Symmers (1966) believes that clinical cystic disease may increase the risk of development of cancer by about four times, while cystic disease which is only discovered with the microscope is less important. Experience in Glasgow suggests that the actual cysts are irrelevant and that the significant phenomenon is accompanying epitheliosis (or epithelial hyperplasia).
I believe that epitheliosis may be an occasional precursor of intraduct cancer but that many cases of intraduct cancer arise without pre-existing epitheliosis. I found in a post-mortem study of the breasts of 800 women who died in the Western Infirmary, Glasgow, that 25 % showed significant epitheliosis. This must mean that the majority of epithelial hyperplasias are harmless. It is fortunate that this is so since some women have epitheliosis in both breasts so that if mastectomy were indicated the bilateral operation would have to be considered.
There is sometimes difficulty in deciding when an intraductal proliferation is simple or malignant. The majority fall clearly into the epitheliosis or intraduct cancer groups. In some more doubtful instances the roundness and symmetry of nuclei and cribriform spheres or feathery fronds with bridges or morular masses will suggest micropapillary intraduct malignancy. Useful features in weighting the diagnosis towards the benign side are differentiation of the cells to a histiocytic type and the presence of abundant myoepithelial cells.
Perhaps the most intersting group of preinvasive conditions at the present time are those in-situ cancers where the lobules and terminal ductules are involved. These do not produce palpable masses and are discovered accidentally in biopsies of otherwise benign lesions, e.g. cystic mastopathy, and this may explain why some apparently simple cystic conditions are followed later by carcinoma. The pick-up rate of this lobular form of carcinoma is directly related to the number of slides examined from such biopsies.
The mean age of these patients with in-situ lobular cancer is 10 years less than those with ordinary infiltrative tumour. It seems likely that, if left untreated for about 10 years, 10 % of women with lobular cancer will develop infiltrative tumour and if left for 20 years perhaps about 33 % will infiltrate. There appears to be a parallel here with carcinoma-in-situ of cervix uteri.
Studies at the Memorial Hospital, New York have shown that empirical biopsy of 20 mm sized pieces of tissue from the periareolar region of the upper outer quadrant of the contralateral breast in women known to have lobular carcinoma will show further lobular carcinoma in up to 15 % of patients. Occasionally even infiltrative cancer will be found in these empirical biopsies of the contralateral breast. When lobular carcinoma does invade, the prognosis is very poor indeed (McDivitt 1972) .
I have shown that 3 % of women with breast cancer coming to autopsy at the Western Infirmary, Glasgow, have tumour in the contralateral breast (Sandison 1962) . I believe that in most cases this is secondary and spreads from the original cancer across the chest wall. Symmers (1966) suggests that up to 5% of women with breast cancer may develop a second primary tumour on the contralateral side, but I feel that this estimate may be too high. Willis (1967) believes that both breasts should be amputated if a patient has bilateral cystic disease with proven carcinoma in one breast. The medical literature is by no means overburdened with information on the psychological consequences of mastectomy. Follow-up reports are, of course, concerned primarily with survival rates, but it is disappointing to find that -apart from references to local postoperative complications -these reports contain no systematic data about the quality of life of the survivors. Not all cancer workers regret this hiatus in knowledge; some, indeed, welcome it. One surgeon, for instance, describes the breast as 'a superficial, easily disposable utilitarian appendage', and actually warns against any study of the reactions of patients to breast amputation; instead, he advocates 'the adoption of a casual attitude by the doctor before operation and throughout follow-up examinations' as a means of avoiding psychological trauma (Watson 1966 
